Panacea Life Sciences Holdings Inc · OTC:PLSH
Panacea Life Sciences — Exactus — Investor Presentation (February 2020)
23 slides from Panacea Life Sciences's investor presentation, Feb 18, 2020
Slide 1: Compliance and Scalability for Mass Market Adoption
“COMPLIANCE AND SCALABILITY - FOR MASS MARKET ADOPTION-... <=
Slide 2: Cautionary Note Regarding Forward-Looking Statements
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements. You can identify forward-looking statements in this presentation by use of the words “potential,” “expect,” “anticipate,” “target” and similar terminology. Such forward-looking statements incl
Slide 3: Building a Trusted Hemp Derivatives Platform
BUILDING A TRUSTED HEMP DERIVATIVES PLATFORM icy \ . Independent laboratory tested products Traceability from cultivation to end consumer a —— Highly scalable hemp farming knowledge base i, 77; & <> MARKET FACTS ZS * OTCQB SYMBOL: EXDI * Market cap ¥$13.5 million* * Fully reporting
Slide 4: Federal Legalization of Hemp
FEDERAL LEGALIZATION OF HEMP 2018 Farm Bill legalized hemp*, shifts hemp production regulation from the Drug Enforcement Agency (DEA) to the United States Department of Agriculture (USDA) at the Federal Level * Significant growth catalyst for industry * Industrial hemp and its byproducts are not inc
Slide 5: US Hemp-Derived CBD Market Forecast
US HEMP-DERIVED CBD MARKET FORECAST Hemp-derived CBD has been gaining huge momentum...We believe the hemp CBD market is going to skyrocket and is here to stay. 2: The Brightfield Grou
Slide 6: The Endocannabinoid System (ECS)
THE ENDOCANNABINOID SYSTEM (ECS) A physiological system of receptor networks supporting Anxiety wanes good health* oe ae ae Potential Health and Wellness Applications for so Hemp Derivatives Inflammatory /{ Epilepsy Seizures Cannabinoids stimulate the receptors located throughout the body and suppor
Slide 7: Experience in Wellness, Health & Farming
EXPERIENCE IN WELLNESS, HEALTH & FARMING EMILIANO ALO! PRESIDENT & CEO Co-founder of Ceed2Med Agro-industrial supply and market development expertise. Co- sponsored research programs for Stevia and Aloe Vera in 2012. &® Gen ~ LOMA NEGRA a 60 & DEREK DU CHESNE KENNETH E. PUZDER ANDREW L. JOHNSON CHIE
Slide 8: Timeline & Milestones
TIMELINE & MILESTONES A Q1 2019 © J Q2 2019 - Executed Ceed2Med - Initiated Master Supply & farming Development Agreement. operations. - Established farming - Acquired location. Green Goddess - Placed initial product Extracts order. consumer products brand. f Q3 2019 - E-commerce platform launched.
Slide 9: Two Industrial Hemp Farms in Oregon
gam AN = PS) Two Industrial Hemp Farms in Oregon * Controlling ownership stake (50.1%) * Superior seed genetics * Successful harvest history * Purchased the rights for 100% of the 2020 harvest Organic and Proprietary Farming Techniques + All-natural processes and products * Top flower harvest for sa
Slide 10: Traceability from Cultivation to Consumer
10 TRACEABILITY FROM CULTIVATION TO CONSUMER GMP Formulations and Manufacturing a ® Retailer Wholesaler @ t Test and Q © Analysis GMP od) Extraction ° (i Certified Genetics Direct to Consumer Consumer All-natural TRANSPARENCY Cultivation Build trust with full Transportation transparency through enti
Slide 11: Full Transparency
FULL TRANSPARENCY Lab Results ¢ Product Description * Product Technical Specifications * Certificate of Analysis of Product * Active Ingredient Technical Specifications * Active Ingredient Third-Party CoA * Strain and Batch Flower Specifications ¢ Strain and Batch Third-Party CoA * Materials Safety
Slide 12: Growth Strategy
GROWTH STRATEGY Developing a Hemp-derived Ecosystem Supported By Best-in-Class Industry Practices Operations Platform Growth Drivers >) Farm = T ice I New Products Marketing and Brand Development & | Processing E Manufacturing Se Expand Distribution exactus We
Slide 13: The Plan: Develop a Hemp-Derived Specialty Ingredients Ecosystem
THE PLAN: DEVELOP A HEMP-DERIVED SPECIALTY INGREDIENTS ECOSYSTEM * Launch Exactus family of branded products = - * Build targeted consumer-facing distribution sos various channels LAA yor , y, * Build brand awareness if r — ™~ vA E-commerce (D2C) Wholesale (B2B) Big-box retail distribution “ Special
Slide 14: Building Out Product Lines
BUILDING OUT PRODUCT LINES exactus Launch Hemp Derived Products yr SS * Tinctures, topicals, edibles and new delivery systems in development @ * Green Goddess Extracts product portfolio targets cada millennial segment through e-commerce and brick and mortar distribution channels * LeVor Collection t
Slide 15: Exactus Branded Products
EXACTUS BRANDED PRODUCTS Build a House of Brands Supported by Exactus’ Quality Strategy: Develop and acquire brands to service under the Exactus ecosystem supported by our standards of quality and compliance . Develop products from our compliant full spectrum of whole plant extract distillates (broa
Slide 16: Distribution Channel Build-Out Plan
16 DISTRIBUTION CHANNEL BUILD-OUT PLAN * Streamlining E-commerce platform and developing an Amazon portal by our highly experienced team with track record of successful algorithm-based sales in similar sectors * Wholesale distribution through existing relationships + Will target pharmacy sales of he
Slide 17: Medical Delivery Systems
MEDICAL DELIVERY SYSTEMS On Nov. 20**, 2019 Exactus signed a Supply & Distribution agreement with Canntab Therapeutics Inc. to produce immediate and extended release tablets. 13 Patents Pending in the United States and Canada covering our proprietary processes and hard pill formulations for: + Exten
Slide 18: Growth Opportunities
GROWTH OPPORTUNITIES Summary Balance Sheet Potential Near-Term Sources of Cash * Sales of top flower Cash $5,686 Se * Sales of hemp-derived specialty ingredients Current Assets 3,255,169 * If needed, closing of second and third Total Assets 11,499,203 tranches of $2mm note Current Liabilities 2,052,
Slide 19: Investment Thesis Summary
INVESTMENT THESIS SUMMARY Controlling ownership in industrial hemp farms assures control and access to high quality hemp supply for commercialization Full control from seed to market provides product quality control and supports brand strength Generating revenue in Q1 of 2020 from distribution of a
Slide 20: Safety and Scalability
SAFETY AND SCALABILITY For further information contact: Emiliano Aloi, President & CEO Email emi@exactusinc.com Andrew Johnson, Chief Strategy Officer Email ajohnson@exactusinc.com exactus Nw exactus IN
Slide 21: Appendix Slides
Appendix Slides
Slide 22: Board of Directors
BOARD OF DIRECTORS BOBBY YAMPOLSKY Director * Founder ECJ Luxe, a family-owned luxury shopping destination that specializes in an array of ultra-exclusive items including everything from high end time pieces, jewelry and diamonds, to exotic cars and yachts. * Co-Founder and CEO of Ceed2Med, LLC, a h
Slide 23: Board of Directors - Continued
BOARD OF DIRECTORS - Continued JOHN PRICE Independent Director + John Price currently serves as Chief Financial Officer, Treasurer and Secretary of SCWorx Corp., a publicly-traded provider of data normalization, application interoperability and big data analytics within the healthcare provider marke